| Ident. | Authors (with country if any) | Title |
|---|
| 000100 |
Richard Camicioli [Canada] ; Jennifer Sabino [Canada] ; Myrlene Gee [Canada] ; Thomas Bouchard [Canada] ; Nancy Fisher [Canada] ; Chris Hanstock [Canada] ; Derek Emery [Canada] ; W. R. Wayne Martin [Canada] | Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia |
| 000106 |
Andrew King ; Satomi Maekawa ; Istvan Bodi ; Claire Troakes [Royaume-Uni] ; Safa Al-Sarraj | Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP‐43 proteinopathies but are only rarely additionally immunopositive for phosphorylation‐dependent TDP‐43 |
| 000121 |
Sook K. Song [Corée du Sud] ; Ji E. Lee [Corée du Sud] ; Hae-Jeong Park [Corée du Sud] ; Young H. Sohn [Corée du Sud] ; Jong Doo Lee [Corée du Sud] ; Phil Hyu Lee [Corée du Sud] | The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status |
| 000125 |
Alison Yarnall [Royaume-Uni] ; Lynn Rochester [Royaume-Uni] ; David J. Burn [Royaume-Uni] | The interplay of cholinergic function, attention, and falls in Parkinson's disease |
| 000202 |
Daniel Weintraub [États-Unis] ; David J. Burn [Royaume-Uni] | Parkinson's disease: The quintessential neuropsychiatric disorder |
| 000204 |
John N. Caviness [États-Unis] ; Lih-Fen Lue [États-Unis] ; Thomas G. Beach [États-Unis] ; Joseph G. Hentz [États-Unis] ; Charles H. Adler [États-Unis] ; Lucia Sue [États-Unis] ; Ramin Sadeghi [États-Unis] ; Erika Driver-Dunckley [États-Unis] ; Virgilio G. Evidente [États-Unis] ; Marwan N. Sabbagh [États-Unis] ; Holly A. Shill [États-Unis] ; Douglas G. Walker [États-Unis] | Parkinson's disease, cortical dysfunction, and alpha‐synuclein |
| 000214 |
Valentina Berti [Italie] ; Alberto Pupi [Italie] ; Lisa Mosconi [États-Unis] | PET/CT in diagnosis of dementia |
| 000215 |
Harriet Quigley [Royaume-Uni] ; Sean J. Colloby [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] | PET imaging of brain amyloid in dementia: a review |
| 000341 |
E. Mulin [France] ; E. Leone [France] ; K. Dujardin [France] ; M. Delliaux [France] ; A. Leentjens [Pays-Bas] ; F. Nobili [Italie] ; B. Dessi [Italie] ; O. Tible [France] ; L. Agüera-Ortiz [Espagne] ; R. S. Osorio [Espagne] ; J. Yessavage [États-Unis] ; D. Dachevsky [Argentine] ; F. Rj. Verhey [Pays-Bas] ; Alfonso J. Cruz Jentoft [Espagne] ; O. Blanc [France] ; P. M Llorca [France] ; P. H. Robert [France] | Diagnostic criteria for apathy in clinical practice |
| 000368 |
John C. Dalrymple-Alford [Nouvelle-Zélande] ; Leslie Livingston [Nouvelle-Zélande] ; Michael R. Macaskill [Nouvelle-Zélande] ; Charlotte Graham [Nouvelle-Zélande] ; Tracy R. Melzer [Nouvelle-Zélande] ; Richard J. Porter [Nouvelle-Zélande] ; Richard Watts [Nouvelle-Zélande] ; Tim J. Anderson [Nouvelle-Zélande] | Characterizing mild cognitive impairment in Parkinson's disease |
| 000524 |
David J. Burn [Royaume-Uni] | The Treatment of Cognitive Impairment Associated with Parkinson's Disease |
| 000579 |
G. Stennis Watson [États-Unis] ; James B. Leverenz [États-Unis] | Profile of Cognitive Impairment in Parkinson's Disease |
| 000587 |
Sarah H. M. Robben [Pays-Bas] ; Monique J. M. Sleegers [Pays-Bas] ; Paul L. J. Dautzenberg [Pays-Bas] ; Floor S. Van Bergen [Pays-Bas] ; Jan-Pieter Ter Bruggen [Pays-Bas] ; Marcel G. M. Olde Rikkert [Pays-Bas] | Pilot study of a three‐step diagnostic pathway for young and old patients with Parkinson's disease dementia: screen, test and then diagnose |
| 000599 |
Kathy Dujardin [France] ; Bruno Dubois [France] ; François Tison [France] ; Franck Durif [France] ; Isabelle Bourdeix [France] ; Jean-Jacques Péré [France] ; Alain Duhamel [France] | Parkinson's disease dementia can be easily detected in routine clinical practice |
| 000610 |
Javier Pagonabarraga [Espagne] ; Jaime Kulisevsky [Espagne] ; Gisela Llebaria [Espagne] ; Carmen García-Sánchez [Espagne] ; Berta Pascual-Sedano [Espagne] ; Mercè Martinez-Corral [Espagne] ; Alexandre Gironell [Espagne] | PDD‐Short Screen: A brief cognitive test for screening dementia in Parkinson's disease |
| 000617 |
Randolph Stephenson [États-Unis] ; David Houghton [États-Unis] ; Sri Sundarararjan [États-Unis] ; Richard L. Doty [États-Unis] ; Matthew Stern [États-Unis] ; Sharon X. Xie [États-Unis] ; Andrew Siderowf [États-Unis] | Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease |
| 000629 |
Gisela Llebaria [Espagne] ; Javier Pagonabarraga [Espagne] ; Mercè Martínez-Corral [Espagne] ; Carmen García-Sánchez [Espagne] ; Berta Pascual-Sedano [Espagne] ; Alexandre Gironell [Espagne] ; Jaime Kulisevsky [Espagne] | Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease |
| 000709 |
Elan D. Louis [États-Unis] | Functional correlates of lower cognitive test scores in essential tremor |
| 000711 |
Cristina Sanchez-Castaneda [Espagne] ; Ramon Rene [Espagne] ; Blanca Ramirez-Ruiz [Espagne] ; Jaume Campdelacreu [Espagne] ; Jordi Gascon [Espagne] ; Carles Falcon [Espagne] ; Matilde Calopa [Espagne] ; Serge Jauma [Espagne] ; Montserrat Juncadella [Espagne] ; Carme Junque [Espagne] | Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia |
| 000726 |
Elizabeth E. Marchani [États-Unis] ; Thomas D. Bird [États-Unis] ; Ellen J. Steinbart [États-Unis] ; Elisabeth Rosenthal [États-Unis] ; Chang-En Yu [États-Unis] ; Gerard D. Schellenberg [États-Unis] ; Ellen M. Wijsman [États-Unis] | Evidence for three loci modifying age‐at‐onset of Alzheimer's disease in early‐onset PSEN2 families |
| 000774 |
Karen Marder [États-Unis] | Cognitive impairment and dementia in Parkinson's disease |
| 000798 |
Min Shi ; Bertrand R. Huber ; Jing Zhang | Biomarkers for Cognitive Impairment in Parkinson Disease |
| 000914 |
James R. Williams [États-Unis] ; Laura Marsh [États-Unis] | Validity of the Cornell scale for depression in dementia in Parkinson's disease with and without cognitive impairment |
| 000989 |
Sebastian Palmqvist [Suède] ; Oskar Hansson [Suède] ; Lennart Minthon [Suède] ; Elisabet Londos [Suède] | Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests |
| 000A40 |
Naroa Ibarretxe-Bilbao [Espagne] ; Eduardo Tolosa [Espagne] ; Carme Junque [Espagne] ; Maria-Jose Marti [Espagne] | MRI and cognitive impairment in Parkinson's disease |
| 000A64 |
David J. Brooks [Royaume-Uni] | Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography |
| 000A66 |
Stefano Zoccolella [Italie] ; Claudia Dell'Aquila [Italie] ; Giovanni Abruzzese [Italie] ; Angelo Antonini [Italie] ; Ubaldo Bonuccelli [Italie] ; Margherita Canesi [Italie] ; Silvano Cristina [Italie] ; Roberta Marchese [Italie] ; Claudio Pacchetti [Italie] ; Roberto Zagaglia [Italie] ; Giancarlo Logroscino [Italie] ; Giovanni Defazio [Italie] ; Paolo Lamberti [Italie] ; Paolo Livrea [Italie] | Hyperhomocysteinemia in levodopa‐treated patients with Parkinson's disease dementia |
| 000A69 |
Maria C. Rodriguez-Oroz [Espagne] ; Pablo Martínez Lage [Espagne] ; Jose Sanchez-Mut [Espagne] ; Isabel Lamet [Espagne] ; Javier Pagonabarraga [Espagne] ; Jon B. Toledo [Espagne] ; David García-Garcia [Espagne] ; Pedro Clavero [Espagne] ; Lluis Samaranch [Espagne] ; Cecilia Irurzun [Espagne] ; Juan M. Matsubara [Espagne] ; Jaione Irigoien [Espagne] ; Emilia Bescos [Espagne] ; Jaime Kulisevsky [Espagne] ; Jordi Pérez-Tur [Espagne] ; Jose A. Obeso [Espagne] | Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study |
| 000A91 |
Kenya Nishioka [Japon, États-Unis] ; Owen A. Ross [États-Unis] ; Kenji Ishii [Japon] ; Jennifer M. Kachergus [États-Unis] ; Kiichi Ishiwata [Japon] ; Mayumi Kitagawa [Japon] ; Satoshi Kono [Japon] ; Tomokazu Obi [Japon] ; Koichi Mizoguchi [Japon] ; Yuichi Inoue [Japon] ; Hisamasa Imai [Japon] ; Masashi Takanashi [Japon] ; Yoshikuni Mizuno [Japon] ; Matthew J. Farrer [États-Unis] ; Nobutaka Hattori [Japon] | Expanding the clinical phenotype of SNCA duplication carriers |
| 000B26 |
Inga Liepelt [Allemagne] ; Matthias Reimold [Allemagne] ; Walter Maetzler [Allemagne] ; Jana Godau [Allemagne] ; Gerald Reischl [Allemagne] ; Alexandra Gaenslen [Allemagne] ; Heinz Herbst [Allemagne] ; Daniela Berg [Allemagne] | Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration—[18F]FDG‐PET |
| 000B33 |
Jaime Kulisevsky [Espagne] ; Javier Pagonabarraga [Espagne] | Cognitive impairment in Parkinson's disease: Tools for diagnosis and assessment |
| 000B45 |
Yaroslau Compta [Espagne] ; María J. Martí [Espagne] ; Naroa Ibarretxe-Bilbao [Espagne] ; Carme Junqué [Espagne] ; Francesc Valldeoriola [Espagne] ; Esteban Mu Oz [Espagne] ; Mario Ezquerra [Espagne] ; Jose Ríos [Espagne] ; Eduardo Tolosa [Espagne] | Cerebrospinal tau, phospho‐tau, and beta‐amyloid and neuropsychological functions in Parkinson's disease |
| 000B65 |
Kathy Dujardin [France] ; Pascal Sockeel [France] ; Marie Delliaux [France] ; Alain Destée [France] ; Luc Defebvre [France] | Apathy may herald cognitive decline and dementia in Parkinson's disease |
| 000B74 |
M. A. Reyes [Argentine, Colombie] ; S. P. Lloret [Argentine] ; E. R. Gerscovich [Argentine] ; M. E. Martin [Argentine] ; R. Leiguarda [Argentine] ; M. Merello [Argentine] | Addenbrooke’s Cognitive Examination validation in Parkinson’s disease |
| 000C53 |
Mariese A. Hely [Australie] ; Wayne G. J. Reid [Australie] ; Michael A. Adena [Australie] ; Glenda M. Halliday [Australie] ; John G. L. Morris [Australie] | The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years |
| 000D13 |
Javier Pagonabarraga [Espagne] ; Jaime Kulisevsky [Espagne] ; Gisela Llebaria [Espagne] ; Carmen García-Sánchez [Espagne] ; Berta Pascual-Sedano [Espagne] ; Alexandre Gironell [Espagne] | Parkinson's disease‐cognitive rating scale: A new cognitive scale specific for Parkinson's disease |
| 000D27 |
Werner Poewe [Autriche] | Non‐motor symptoms in Parkinson’s disease |
| 000D34 |
Chelsea Stamper [États-Unis] ; Andrew Siegel [États-Unis] ; Winnie S. Liang [États-Unis] ; John V. Pearson [États-Unis] ; Dietrich A. Stephan [États-Unis] ; Holly Shill [États-Unis] ; Don Connor [États-Unis] ; John N. Caviness [États-Unis] ; Marwan Sabbagh [États-Unis] ; Thomas G. Beach [États-Unis] ; Charles H. Adler [États-Unis] ; Travis Dunckley [États-Unis] | Neuronal gene expression correlates of Parkinson's disease with dementia |
| 000E04 |
K. Imamura [Japon] ; K. Wada-Isoe [Japon] ; M. Kitayama [Japon] ; K. Nakashima [Japon] | Executive dysfunction in non‐demented Parkinson’s disease patients with hallucinations |
| 000E31 |
Gisela Llebaria [Espagne] ; Javier Pagonabarraga [Espagne] ; Jaime Kulisevsky [Espagne] ; Carmen García-Sánchez [Espagne] ; Berta Pascual-Sedano [Espagne] ; Alexandre Gironell [Espagne] ; Mercè Martínez-Corral [Espagne] | Cut‐off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease |
| 000E63 |
K. Wada-Isoe [Japon] ; K. Ohta [Japon] ; K. Imamura [Japon] ; M. Kitayama [Japon] ; T. Nomura [Japon] ; K. Yasui [Japon] ; K. Nakaso [Japon] ; K. Nakashima [Japon] | Assessment of hallucinations in Parkinson’s disease using a novel scale |
| 000E79 |
Javier Pagonabarraga [Espagne] ; Gisela Llebaria [Espagne] ; Carmen García-Sánchez [Espagne] ; Berta Pascual-Sedano [Espagne] ; Alexandre Gironell [Espagne] ; Jaime Kulisevsky [Espagne] | A prospective study of delusional misidentification syndromes in Parkinson's disease with dementia |
| 000F49 |
Frauke Boddy [Royaume-Uni] ; Elise N. Rowan [Royaume-Uni] ; Debbie Lett [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] ; David J. Burn [Royaume-Uni] | Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease |
| 000F68 |
G. Waldemar [Danemark] ; B. Dubois [France] ; M. Emre [Turquie] ; J. Georges [Luxembourg (pays)] ; I. G. Mckeith [Royaume-Uni] ; M. Rossor [Royaume-Uni] ; P. Scheltens [Pays-Bas] ; P. Tariska [Hongrie] ; B. Winblad [Suède] | Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline |
| 001024 |
Selma Aybek [Suisse] ; Aline Gronchi-Perrin [Suisse] ; Alexandre Berney [Suisse] ; Sabina Catalano Chiuvé [Suisse] ; Jean-Guy Villemure [Suisse] ; Pierre R. Burkhard [Suisse] ; François J. G. Vingerhoets [Suisse] | Long‐term cognitive profile and incidence of dementia after STN‐DBS in Parkinson's disease |
| 001031 |
Lindsy N. Williams [États-Unis] ; Paul Seignourel [États-Unis] ; Gregory P. Crucian [États-Unis] ; Michael S. Okun [États-Unis] ; Ramon L. Rodriguez [États-Unis] ; Frank M. Skidmore [États-Unis] ; Paul S. Foster [États-Unis] ; Charles E. Jacobson Iv [États-Unis] ; Janet Romrell [États-Unis] ; Dawn Bowers [États-Unis] ; Hubert H. Fernandez [États-Unis] | Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease |
| 001082 |
H. Matsui [Japon] ; K. Nishinaka [Japon] ; M. Oda [Japon] ; H. Niikawa [Japon] ; T. Kubori [Japon] ; F. Udaka [Japon] | Dementia in Parkinson’s disease: diffusion tensor imaging |
| 001134 |
Gabriella Santangelo [Italie] ; Luigi Trojano [Italie] ; Carmine Vitale [Italie] ; Marta Ianniciello [Italie] ; Marianna Amboni [Italie] ; Dario Grossi [Italie] ; Paolo Barone [Italie] | A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations |
| 001203 |
Heather L. Katzen [États-Unis] ; Bonnie E. Levin [États-Unis] ; William Weiner [États-Unis] | Side and type of motor symptom influence cognition in Parkinson's disease |
| 001225 |
Nathan Pankratz [États-Unis] ; Lisa Byder [États-Unis] ; Cheryl Halter [États-Unis] ; Alice Rudolph [États-Unis] ; Clifford W. Shults [États-Unis] ; P. Michael Conneally [États-Unis] ; Tatiana Foroud [États-Unis] ; William C. Nichols [États-Unis] | Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia |
| 001226 |
Ergun Y. Uc [États-Unis] ; Lynn K. Struck [États-Unis] ; Robert L. Rodnitzky [États-Unis] ; Bridget Zimmerman [États-Unis] ; Judith Dobson [États-Unis] ; William J. Evans [États-Unis] | Predictors of weight loss in Parkinson's disease |
| 001239 |
François Sellal [France] | Parkinson's disease with dementia and dementia with Lewy body disease: two syndromes, the same disease? |
| 001274 |
M. A. Slifer [États-Unis] ; E. R. Martin [États-Unis] ; P. G. Bronson [États-Unis] ; C. Browning-Large [États-Unis] ; P. M. Doraiswamy [États-Unis] ; K. A. Welsh-Bohmer [États-Unis] ; J. R. Gilbert [États-Unis] ; J. L. Haines [États-Unis] ; M. A. Pericak-Vance [États-Unis] | Lack of association between UBQLN1 and Alzheimer disease |
| 001296 |
L. Joseph Melton Iii [États-Unis] ; Cynthia L. Leibson [États-Unis] ; Sara J. Achenbach [États-Unis] ; James H. Bower [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Ann L. Oberg [États-Unis] ; Walter A. Rocca [États-Unis] | Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia |
| 001340 |
Debra L. Schutte [États-Unis] ; Ezra C. Holston [États-Unis] | Chronic Dementing Conditions, Genomics, and New Opportunities for Nursing Interventions |
| 001357 |
B. Feldman [Israël] ; J. Chapman [Israël] ; A. D. Korczyn [Israël] | Apolipoprotein ɛ4 advances appearance of psychosis in patients with Parkinson's disease |
| 001399 |
Hasmet A. Hanagasi ; Murat Emre [Turquie] | Treatment of behavioural symptoms and dementia in Parkinson's disease |
| 001404 |
K. Haugarvoll [Norvège] ; D. Aarsland [Norvège] ; T. Wentzel-Larsen [Norvège] ; J. P. Larsen [Norvège] | The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease |
| 001409 |
He Le Ne Amieva ; He Le Ne Jacqmin-Gadda ; Jean-Marc Orgogozo ; Nicolas Le Carret ; Catherine Helmer ; Luc Letenneur ; Pascale Barberger-Gateau ; Colette Fabrigoule ; Jean-Franc Ois Dartigues | The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study |
| 001441 |
Louise M. Allan [Royaume-Uni] ; Clive G. Ballard [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Rose Anne Kenny [Royaume-Uni] | Prevalence and Severity of Gait Disorders in Alzheimer's and Non‐Alzheimer's Dementias |
| 001455 |
Charles H. Adler [États-Unis] | Nonmotor complications in Parkinson's disease |
| 001511 |
S. Papapetropoulos [États-Unis] ; J. Gonzalez [États-Unis] ; A. Lieberman [États-Unis] ; J. M. Villar [États-Unis] ; D. C. Mash [États-Unis] | Dementia in Parkinson's disease: a post‐mortem study in a population of brain donors |
| 001533 |
Richard Camicioli [Canada] ; Ali Rajput [Canada] ; Michelle Rajput [Canada] ; Christian Reece [Canada] ; Haydeh Payami [États-Unis] ; Chunhai Hao [Canada] ; Alex Rajput [Canada] | Apolipoprotein E ϵ4 and catechol‐O‐methyltransferase alleles in autopsy‐proven Parkinson's disease: Relationship to dementia and hallucinations |
| 001537 |
Carme Junqué [Espagne] ; Blanca Ramírez-Ruiz [Espagne] ; Eduardo Tolosa [Espagne] ; Christopher Summerfield [Espagne] ; María-José Martí [Espagne] ; Pau Pastor [Espagne] ; Beatriz G Mez-Ans N [Espagne] ; José Ma. Mercader [Espagne] | Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia |
| 001583 |
Iracema Leroi [Royaume-Uni, États-Unis] ; Jason Brandt [États-Unis] ; Stephen G. Reich [États-Unis] ; Constantine G. Lyketsos [États-Unis] ; Stephen Grill [États-Unis] ; Richard Thompson [États-Unis] ; Laura Marsh [États-Unis] | Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease |
| 001681 |
Murat Emre [Turquie] | What causes mental dysfunction in Parkinson's disease? |
| 001683 |
David J. Burn [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] | Use of functional imaging in parkinsonism and dementia |
| 001698 |
Sudeep S. Gill [Canada] ; Paula A. Rochon [Canada] ; Mark Guttman [Canada] ; Andreas Laupacis | The Value of Positron Emission Tomography in the Clinical Evaluation of Dementia |
| 001721 |
Frank L. Mastaglia [Australie] ; Russell D. Johnsen [Australie] ; Michelle L. Byrnes [Australie] ; Byron A. Kakulas [Australie] | Prevalence of amyloid‐β deposition in the cerebral cortex in Parkinson's disease |
| 001728 |
Richard Camicioli [États-Unis, Canada] ; M. Milar Moore [États-Unis] ; Anthony Kinney [États-Unis] ; Elizabeth Corbridge [États-Unis] ; Kathryn Glassberg [États-Unis] ; Jeffrey A. Kaye [États-Unis] | Parkinson's disease is associated with hippocampal atrophy |
| 001793 |
David J. Burn [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] | Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease |
| 001828 |
P. H. Robert [France] ; S. Clairet [France] ; M. Benoit [France] ; J. Koutaich [France] ; C. Bertogliati [France] ; O. Tible [France] ; H. Caci [France] ; M. Borg [France] ; P. Brocker [France] ; P. Bedoucha [France] | The Apathy Inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment |
| 001876 |
Gilberto Levy [États-Unis] ; Diane M. Jacobs [États-Unis] ; Ming-Xin Tang [États-Unis] ; Lucien J. Côté [États-Unis] ; Elan D. Louis [États-Unis] ; Brenda Alfaro [États-Unis] ; Helen Mejia [États-Unis] ; Yaakov Stern [États-Unis] ; Karen Marder [États-Unis] | Memory and executive function impairment predict dementia in Parkinson's disease |
| 001882 |
Juan L. Sánchez ; Marina Rodríguez [Espagne] ; Juan Carro | Influence of cognitive reserve on neuropsychological functioning in Parkinson's disease |
| 001907 |
Gilberto Levy [États-Unis] ; Ming-Xin Tang [États-Unis] ; Lucien J. Cote [États-Unis] ; Elan D. Louis [États-Unis] ; Brenda Alfaro [États-Unis] ; Helen Mejia [États-Unis] ; Yaakov Stern [États-Unis] ; Karen Marder [États-Unis] | Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study |
| 001A25 |
Ram N Cacabelos | Psychogeriatric Research: A Conceptual Introduction to Aging and Geriatric Neuroscience |
| 001C00 |
Louise M. Waite [Australie] ; G. Anthony Broe [Australie] ; David A. Grayson [Australie] ; Helen Creasey [Australie] | Motor function and disability in the dementias |
| 001C26 |
Gilles Fe Nelon ; Florence Mahieux ; Renaud Huon ; Marc Zie Gler | Hallucinations in Parkinson's disease |
| 001F28 |
Th. Benke [Autriche] ; S. Bösch [Autriche] ; B. Andree [Autriche] | A Study of Emotional Processing in Parkinson's Disease |
| 002023 |
Lutz M. Drach [Allemagne] ; Hans E. E. Steinmetz [Allemagne] ; Stefanie Wach [Allemagne] ; Jürgen Bohl [Allemagne] | HIGH PROPORTION OF DEMENTIA WITH LEWY BODIES IN THE POSTMORTEMS OF A MENTAL HOSPITAL IN GERMANY |
| 002157 |
Alan M. Palmer | Neurochemical Studies of Alzheimer's Disease |
| 002207 |
J. J. Claus [Pays-Bas] ; E. Mohr [Canada] | Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseases |
| 002354 |
Lissy F. Jarvik [États-Unis] ; Steven S. Matsuyama [États-Unis] ; Helena Chui [États-Unis] ; Arnold B. Scheibel [États-Unis] ; Harry V. Vinters [États-Unis] | Autopsy diagnoses of Alzheimer disease: Independent reviews and clinical implications |
| 002603 |
J. C. Pin [France] ; J. P. Neau [France] ; J. Paquereau [France] ; C. Rostykus [France] ; D. Guehl [France] ; I. Aubert [France] ; A. Marillaud [France] ; R. Gil [France] | Étude comparative de la démence de type Alzheimer et de celle de la maladie de Parkinson en EEG quantifiée |
| 002779 |
R. F. Peppard ; W. R. W. Martin ; C. M. Clark ; G. D. Carr ; P. L. Mcgeer ; D. B. Calne | Cortical glucose metabolism in parkinson's and alzheimer's disease |
| 002981 |
Merle Ruberg [France] ; François Rieger [France] ; Albert Villageois [France] ; Anne Marie Bonnet ; Yves Agid [France] | Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease |
| 002A10 |
John P. Blass [États-Unis] ; Laurie L. Barclay [États-Unis] | New developments in the diagnosis of the dementias |
| 002A80 |
U. K. Rinne [Finlande] | Problems associated with long‐term levodopa treatment of Parkinson's disease |
